Oncological patient management on the territory: The results of a survey in the north-west of Italy

Main Article Content


Community pharmacy, Oncological patients, Oncological therapies, Disease acceptance, Survey, Patients management


Objective: To investigate the role of community pharmacists in the therapeutic process of oncological patients and to assess these patients’ state of acceptance of their disease and their relationship with their therapies, we performed a survey in some oncological clinics in Turin (north-west of Italy). Methods: The survey was carried out in a three months’ period by means of a questionnaire. The questionnaire was administered on paper to oncological patients that attended 5 oncological clinics in Turin. The questionnaire was self-administered. Results: 266 patients filled out the questionnaire. More than half of patients reported that their cancer diagnosis interfered with normal life very much or extremely and almost 70% of patients reported that they were accepting of what happened and were trying to fight back. 65% of patients answered that it is important or very important that pharmacists are aware of their health status. About 3 out of 4 patients thought that pharmacists giving information on medicines purchased and on how to use them is important or very important and that it is important to receive information concerning health and the effects of medication taken. Conclusion: Our study underlines the role of territorial health units in the management of oncological patients. It can be said that the community pharmacy is certainly a channel of election, not only in cancer prevention but also in the management of those patients who have already been diagnosed with cancer. More comprehensive and specific pharmacist training is necessary for the management of this type of patient. Furthermore, it is necessary to improve the awareness of this issue in community pharmacists at the local and national levels by creating a network of qualified pharmacies developed in collaboration with oncologists, GPs, dermatologists, psychologists and cosmetics companies.

Abstract 483 | PDF Downloads 512


1. World Health Organization. Cancer: Overview. 2022. Accessed April 4, 2022. https://www.who.int/health-topics/cancer#tab=tab_1
2. World Health Organization. Cancer: key facts. 2022. Accessed April 4, 2022. https://www.who.int/news-room/fact-sheets/detail/cancer
3. European Commission. 2021 Communication from the Commission to the European Parliament and the Council.Europe’s Beating Cancer Plan. March 3, 2021. Accessed April 4, 2022. https://eur-lex.europa.eu/legal-content/en/TXT/?uri=COM%3A2021%3A44%3AFIN
4. International Agency for research on Cancer. Cancer Today 2020. Accessed April 4, 2022. https://gco.iarc.fr/today/home
5. Fondazione AIRC per la Ricerca sul Cancro. Le statistiche del cancro. 2021. Accessed April 4, 2022. https://www.airc.it/cancro/
informazioni-tumori/cose-il-cancro/numeri-delcancro#:~:text=L%27incidenza%20dei%20tumori%20in%20Italia%20Si%20 stima%20che,una%20donna%20su%203%20si%20ammaler%C3%A0%20di%20tumore
6. Associazione Italiana di Oncologia Medica. I numeri del cancro in italia. 2021. Accessed April 4, 2022 https://www.aiom.it/wp-content/uploads/2021/10/2021_NumeriCancro_web.pdf
7. World Health Organization. Cancer: Prevention. 2022. Accessed April 4, 2022. https://www.who.int/health-topics/cancer#tab=tab_2
8. Lewandowska AM, Rudzki M, Rudzki S, et al. Environmental risk factors for cancer - review paper. Ann Agric Environ Med.2019;26(1):1-7. https://doi.org/10.26444/aaem/94299
9. Kerr J, Anderson C, Lippman SM. Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet Oncol. 2017;18(8):e457-e471. https://doi.org/10.1016/S1470-2045(17)30411-4
10. Marur S, D’Souza G, Westra WH, et al. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11(8):781-789. https://doi.org/10.1016/S1470-2045(10)70017-6
11. Vieira AR, Abar L, Chan DSM, et al. Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update Project. Ann Oncol. 2017;28(8):1788-1802.https://doi.org/10.1093/annonc/mdx171
12. Vieira AR, Abar L, Vingeliene S, et al. Fruits, vegetables and lung cancer risk: a systematic review and meta-analysis. Ann Oncol.2016;27(1):81-96. https://doi.org/10.1093/annonc/mdv381
13. Modenese A, Korpinen L, Gobba F. Solar Radiation Exposure and Outdoor Work: An Underestimated Occupational Risk. Int JEnviron Res Public Health. 2018;15(10):2063. Published 2018 Sep 20. https://doi.org/10.3390/ijerph15102063
14. Wogan GN, Kensler TW, Groopman JD. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review. Food Addit Contam Part a Chem Anal Control Expo Risk Assess. 2012;29(2):249-257. https://doi.org/10. 1080/19440049.2011.563370
15. Berrino F. Life style prevention of cancer recurrence: the yin and the yang. Cancer Treat Res. 2014;159:341-351. https://doi.org/10.1007/978-3-642-38007-5_20
16. U.S. Department of Health and Human Services, National Cancer Institute. Side Effects of Cancer Treatment. 2022. Accessed April 4, 2022. https://www.cancer.gov/about-cancer/treatment/side-effects
17. Pharmaceutical Group of the European Union. Annual report 2017. Measuring health outcomes in community pharmacy. 2017. Accessed April 4, 2022. https://www.pgeu.eu/wp-content/uploads/2019/04/PGEU-AR-2017-WEB.pdf
18. Kübler-Ross E. On death and dying. Macmillan Company; 1969.
19. Pignata I, Vicenzi G, Ravetto Enri L, et al. The importance of a multidisciplinary care: community pharmacies as a hub to 
support oncologic patients with cutaneous reactions due to treatments. Ital J Dermatol Venerol. 2021;156(6):79-80. https://doi.org/10.23736/S2784-8671.19.06418-6
20. Fondazione AIRC per la Ricerca sul Cancro. Tumore del seno. 2021. Accessed April 4, 2022. https://www.airc.it/cancro/informazioni-tumori/guida-ai-tumori/tumore-del-seno
21. Fondazione AIRC per la Ricerca sul Cancro. Tumore del pancreas. 2018. Accessed April 4, 2022. https://www.airc.it/cancro/informazioni-tumori/guida-ai-tumori/tumore-del-pancreas
22. World Health Organization. Adherence to long term therapies: evidence for action. Edited by Eduardo Sabaté; 2003.
23. Haynes RB, Montague P, Oliver T, et al. Interventions for helping patients to follow prescriptions for medications. Cochrane  Database Syst Rev. 2000;(2):CD000011. https://doi.org/10.1002/14651858.CD000011
24. Fliedner M, Kellerhals SD, Aerts E. Aderenza alle terapie farmacologiche anti-tumorali per via orale. European group for blood
and marrow transplantation. Swiss working group. 2013. Accessed April 4, 2022. https://www.ebmt.org/sites/default/files/migration_legacy_files/document/Practical%20Guide%20for%20Nurses_Adherance%20to%20Oral%20Anti-tumour%20
25. Wood L. A review on adherence management in patients on oral cancer therapies. Eur J Oncol Nurs. 2012;16(4):432-438.

Most read articles by the same author(s)